ERBB2 and breast carcinoma: The high frequency of mutations detected in probants lacking obvious family history indicates the necessity to provide wide criteria for qualifying breast cancer women for genetic testing including pathological (high grade, medullary histology, negative oestrogen and progesterone receptors, and HER-2/neu status) and clinical (age, mammography) parameters of patients [20–22].